SCHEMBL6286696

SCHEMBL6286696

Cc1[nH]c2ccc(OC(F)(F)F)cc2c1CC(=O)O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 1/20 0.72
MEN1 O00255 4/20 0.63
KMT2A Q03164 4/20 0.63
GAA P10253 4/20 0.63
KDM4E B2RXH2 4/20 0.63
MAPT P10636 4/20 0.63
ALDH1A1 P00352 2/20 0.63
PTGS2 P35354 3/20 0.62
PTGS1 P23219 2/20 0.62
CYP2C9 P11712 1/20 0.60
CASP1 P29466 1/20 0.55
CASP7 P55210 1/20 0.55
NPC1 O15118 2/20 0.51
RAB9A P51151 1/20 0.51
POLB P06746 1/20 0.48
NPSR1 Q6W5P4 2/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
TRPV1 Q8NER1 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Deschlorobenzoyl Indomethacin SCHEMBL454792 0.84 AKR1C2 (1.00) AKR1C2MEN1KMT2AGAAKDM4E
SCHEMBL6291091 0.80 KDM4E (0.68) AKR1C2MEN1KMT2AGAAKDM4E
SCHEMBL3408821 0.78 KDM4E (0.73) AKR1C2MEN1KMT2AGAAKDM4E
SCHEMBL6169141 0.78 PTGS2 (1.00) AKR1C2MEN1KMT2AGAAKDM4E
SCHEMBL6102581 0.78 KDM4E (1.00) AKR1C2MEN1KMT2AGAAKDM4E
SCHEMBL30854920 0.78 KDM4E (1.00) AKR1C2MEN1KMT2AGAAKDM4E
SCHEMBL13802390 0.78 AKR1C2 (0.69) AKR1C2MEN1KMT2AGAAKDM4E
SCHEMBL6171126 0.77 PTGS2 (0.62) AKR1C2MEN1KMT2AKDM4EMAPT
SCHEMBL3384980 0.77 MEN1 (0.61) MEN1KMT2AMAPTCYP2C9NPC1
SCHEMBL2643401 0.77 CYP2C9 (0.60) MEN1KMT2AGAAKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK AKR1C2 2816/4885MEN1 111/4885KMT2A 2704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.